Intercept Pharmaceuticals Competitors and Similar CompaniesClear all

Intercept Pharmaceuticals's competitors and similar companies include Promethera Biosciences, Genentech, Ipsen and CSL Behring.

	Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.	Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Ipsen Ipsen is a biopharmaceutical company.	CSL Behring CSL Behring is a provider of life-saving medicines.
Founding Date	Founding Date 2002	Founding Date 2009	Founding Date 1976	Founding Date 1929	Founding Date 1904
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more	Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more
Employees	Employees 58321% increase	Employees 185% decrease	Employees 18,077	Employees 5,358	Employees 7,5692% decrease
Valuation ($)	Valuation ($) 794.7 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 10.2 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $285.7m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €3.7b (FY, 2025)	Revenue (est.) $7.9b (FY, 2020)
Cost of goods	Cost of goods $984k (FY, 2022)	Cost of goods N/A	Cost of goods N/A	Cost of goods €659.1m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $284.7m (FY, 2022)	Gross profit N/A	Gross profit N/A	Gross profit €3.3b (FY, 2025)	Gross profit $4.5b (FY, 2020)
Net income	Net income $221.8m (FY, 2022)	Net income N/A	Net income N/A	Net income €445.1m (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 55m	Total funding raised $ 146m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A